From the alarming reality that nearly a quarter of Americans used illicit drugs in a single year to the devastating surge in overdose deaths, the statistics on drug abuse paint a picture of a complex global crisis demanding our urgent attention.
Key Takeaways
- In 2021, approximately 70.4 million people aged 12 or older in the United States had used illicit drugs in the past year, representing 25.0% of the population
- Globally, an estimated 296 million people used drugs in 2021, which is 5.8% of the world's population aged 15-64
- In the US, past-month marijuana use among adults aged 18-25 reached 25.6% in 2022
- Fentanyl-involved overdose deaths surged to 73,654 in US in 2022
- Opioid overdose deaths totaled 81,806 in US in 2022
- Alcohol contributes to 178,000 deaths annually in US, including from drug interactions
- Drug abuse costs US healthcare system $78.5 billion annually in treatment
- Total economic cost of drug abuse in US was $1.02 trillion in 2017
- Opioid crisis cost US $1.02 trillion from 2015-2020 including productivity losses
- In US, 18-25 year old males have highest illicit drug use rate at 39.5% past year 2021
- Non-Hispanic whites had 24.4% past-year illicit drug use rate in US 2021
- Among US adults 12+, males had 28.1% past-year drug use vs 22.1% females 2021
- In 2021, 2.3 million US people received specialty treatment for drug use disorder
- Only 10.4% of US people with SUD received treatment in 2021
- Medication-assisted treatment (MAT) reduces opioid OD death risk by 50%
Widespread drug abuse affects millions globally, costing lives and creating a trillion-dollar crisis demanding better treatment access.
Demographics
- In US, 18-25 year old males have highest illicit drug use rate at 39.5% past year 2021
- Non-Hispanic whites had 24.4% past-year illicit drug use rate in US 2021
- Among US adults 12+, males had 28.1% past-year drug use vs 22.1% females 2021
- Urban residents in US had 27.1% past-year illicit drug use vs 20.5% rural 2021
- High school dropouts have 2x drug use rates vs graduates in US
- LGBTQ+ youth report 40% higher substance use than heterosexual peers
- In US, 12.1% of adults 26+ with full-time employment used illicit drugs past month 2021
- American Indian/Alaska Native adults have highest opioid OD death rate 56.6/100k
- Low-income (<$20k) US households had 33.6% past-year drug use rate 2021
- College non-enrollees aged 18-22 had 40.2% past-year marijuana use vs 34.6% enrollees
- Black non-Hispanic US adults 18+ had 29.8% past-year marijuana use 2021
- Females aged 12-17 had higher inhalant misuse rates than males in US 2021
- Homeless individuals have 5x higher drug use disorder rates
- In US, past-year cocaine use highest among 18-25 year olds at 5.2% 2021
- Hispanic adults had 25.5% past-year illicit drug use in US 2021
- Unemployed US adults 18+ had 35.4% past-month alcohol use disorder rate higher
- Veterans have 11% past-year prescription misuse rate vs 4.4% civilians
- Rural US counties saw 50% higher opioid prescription rates historically
- Asian non-Hispanic adults lowest drug use at 15.1% past year US 2021
Demographics Interpretation
While these statistics paint a vivid landscape of American drug use—from stressed college non-enrollees to unemployed veterans and disproportionately affected indigenous communities—they collectively sketch less a portrait of moral failing and more a distressingly precise map of where our social safety nets, healthcare systems, and economic opportunities are most catastrophically threadbare.
Economic Impact
- Drug abuse costs US healthcare system $78.5 billion annually in treatment
- Total economic cost of drug abuse in US was $1.02 trillion in 2017
- Opioid crisis cost US $1.02 trillion from 2015-2020 including productivity losses
- Lost productivity from drug disorders costs US $125 billion yearly
- Criminal justice costs for drug abuse $181 billion annually in US
- Workplace absenteeism due to drug use costs employers $84 billion/year US
- Global illicit drug trade valued at $650 billion in 2022
- Methamphetamine production and distribution costs US $23.4 billion yearly
- Alcohol misuse costs US $249 billion annually in healthcare and lost productivity
- Prescription opioid misuse economic burden $78.5 billion in US 2013
- Tobacco use costs US economy $300 billion per year
- Drug-related hospitalizations cost US $81 billion in 2017
- Premature deaths from drugs cost US $200 billion in productivity losses yearly
- Illicit drug use reduces US GDP by 0.4-0.8% annually
- Heroin epidemic costs US $51 billion per year in treatment and crime
- Cocaine use economic costs $193 billion globally per year
- Drug court programs save $4,000-$12,000 per participant annually
- Family members of addicts lose $36 billion in income support yearly US
- Emergency dept visits for drugs cost $11 billion yearly in US
Economic Impact Interpretation
While the nation's ledgers hemorrhage over a trillion dollars annually in lost lives, productivity, and justice, it's clear we're paying an astronomical price to prosecute, hospitalize, and mourn an enemy we've yet to decisively treat.
Health Effects
- Fentanyl-involved overdose deaths surged to 73,654 in US in 2022
- Opioid overdose deaths totaled 81,806 in US in 2022
- Alcohol contributes to 178,000 deaths annually in US, including from drug interactions
- Chronic opioid use leads to addiction in 8-12% of patients post-surgery
- Methamphetamine use associated with 33,000 overdose deaths in US 2022
- Cocaine-related overdose deaths reached 27,569 in US 2022
- Benzodiazepine involvement in 13,369 overdose deaths in US 2022
- Heavy alcohol use increases risk of liver cirrhosis by 10-fold
- Opioid use disorder linked to 50% increased risk of HIV acquisition
- Smoking during pregnancy increases low birth weight risk by 50%
- Long-term cannabis use associated with 40% higher risk of schizophrenia in predisposed individuals
- Heroin injection leads to endocarditis in 20-30% of chronic users
- Stimulant use increases stroke risk by 24% in young adults
- Alcohol misuse contributes to 95,000 cancer deaths yearly worldwide
- Fentanyl depresses respiration, causing 70% of opioid OD deaths hypoxic
- Meth mouth affects 30-40% of chronic meth users with severe dental decay
- Polysubstance use involved in 94% of overdose deaths in US 2022
- Chronic cocaine use causes cardiomyopathy in up to 20% of users
- Opioid-induced constipation affects 40-80% of chronic users
- Binge drinking leads to 1 in 6 adult deaths in US over average lifespan
- Synthetic cannabinoids cause acute kidney injury in 30% of severe cases
- Heroin users have 19-fold increased mortality risk vs general population
- Alcohol withdrawal seizures occur in 6-10% of dependent patients
Health Effects Interpretation
In a grim ledger of modern afflictions, we seem to have mastered the art of trading fleeting escape for a staggering collection of permanent consequences, from individual ruin to a national death toll that reads like a war report.
Prevalence
- In 2021, approximately 70.4 million people aged 12 or older in the United States had used illicit drugs in the past year, representing 25.0% of the population
- Globally, an estimated 296 million people used drugs in 2021, which is 5.8% of the world's population aged 15-64
- In the US, past-month marijuana use among adults aged 18-25 reached 25.6% in 2022
- Opioid use disorder affected 6.1 million people aged 12 or older in the US in 2021
- About 18 million people in the US misused prescription pain relievers in the past year in 2021
- Lifetime cocaine use prevalence among US high school seniors was 10.3% in 2022
- In Europe, 8.4% of adults aged 15-64 had used cannabis in the past year in 2022
- Methamphetamine use in the past year among US adults aged 12+ was 2.7 million in 2021
- Hallucinogen use in the past year reached 8.2 million people in the US in 2021
- Inhalant misuse past year among US youth aged 12-17 was 1.7 million in 2021
- Global amphetamine-type stimulant use was 37 million people in 2021
- Past-month use of illicit drugs other than marijuana was 8.8% among US young adults 18-25 in 2021
- Heroin use in the past year affected 1.3 million US people aged 12+ in 2021
- In 2022, 4.8% of US 12th graders reported past-year ecstasy/MDMA use
- Sedative misuse past year was 4.8 million among US adults 12+ in 2021
- Global cocaine use reached 22 million people aged 15-64 in 2021
- Past-year nonmedical use of stimulants was 5.1 million in US 2021
- Cannabis use disorder prevalence was 10.2% among past-year users in US 2021
- In Australia, 11.0% of population aged 14+ used illicit drugs in past 12 months in 2022-23
- UK past-year drug use among 16-59 year olds was 10.7% in 2022/23
- In 2021, 2.7 million US adolescents aged 12-17 used illicit drugs past month
Prevalence Interpretation
Despite these stark numbers painting a global portrait of dependency—from classrooms to continents—it seems humanity's pursuit of altered consciousness remains a tragically popular, and perilous, pastime.
Treatment Outcomes
- In 2021, 2.3 million US people received specialty treatment for drug use disorder
- Only 10.4% of US people with SUD received treatment in 2021
- Medication-assisted treatment (MAT) reduces opioid OD death risk by 50%
- Buprenorphine treatment retention averages 50% at 6 months
- Contingency management boosts stimulant abstinence by 50%
- 12-step programs like NA show 20-30% abstinence at 1 year
- In US, 48.5% of treatment admissions were for opioids in 2021
- Methadone maintenance reduces illicit opioid use by 70%
- Relapse rate within 1 year post-treatment is 40-60% for SUD
- Cognitive behavioral therapy (CBT) effective for 50-60% cocaine dependence remission
- Naloxone distribution reduced overdose deaths by 14% in communities
- Residential treatment completion rate 60% leads to 70% sobriety at 1 year
- MAT for alcohol (acamprosate) sustains abstinence 20% longer
- Outpatient treatment cheaper at $7,000/year vs $30,000 residential
- Vivitrol (naltrexone) reduces opioid relapse by 50% in trials
- Only 19% of US youth with SUD receive any treatment
- Long-term recovery rates 10-30% sustained 5+ years with support
- Telehealth SUD treatment increased access by 20% during COVID
- Heroin users in MMT have 59% lower mortality risk
Treatment Outcomes Interpretation
While we possess a formidable arsenal of evidence-backed treatments that can dramatically improve and save lives—from cutting overdose deaths in half to slashing illicit drug use by 70%—the stark reality remains that our system is like a brilliant but understaffed lifeboat, leaving the vast majority of those struggling to tread water as we celebrate the few we manage to pull aboard.
Sources & References
- Reference 1SAMHSAsamhsa.govVisit source
- Reference 2UNODCunodc.orgVisit source
- Reference 3NIDAnida.nih.govVisit source
- Reference 4CDCcdc.govVisit source
- Reference 5MONITORINGTHEFUTUREmonitoringthefuture.orgVisit source
- Reference 6EMCDDAemcdda.europa.euVisit source
- Reference 7AIHWaihw.gov.auVisit source
- Reference 8GOVgov.ukVisit source
- Reference 9NEJMnejm.orgVisit source
- Reference 10NIAAAniaaa.nih.govVisit source
- Reference 11NCBIncbi.nlm.nih.govVisit source
- Reference 12AHAJOURNALSahajournals.orgVisit source
- Reference 13WHOwho.intVisit source
- Reference 14JOURNALSjournals.plos.orgVisit source
- Reference 15RANDrand.orgVisit source
- Reference 16ASAMasam.orgVisit source
- Reference 17NCJRSncjrs.govVisit source
- Reference 18VAva.govVisit source